92 related articles for article (PubMed ID: 25804227)
1. In vitro and in vivo evaluation of 2-chloroethylnitrosourea derivatives as antitumor agents.
Sen A; Goswami KK; Mallick A; Saxena AK; Sanyal U; Baral R
Exp Oncol; 2015 Mar; 37(1):23-9. PubMed ID: 25804227
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agent.
Samanta S; Pain A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2002 Mar; 21(1):87-93. PubMed ID: 12071535
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of ethylnitrosoureas of substituted naphthalimides as anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Sharma M; Qazi GN; Sanyal U
Acta Pol Pharm; 2007; 64(1):27-33. PubMed ID: 17665847
[TBL] [Abstract][Full Text] [Related]
4. Comparative investigation of the effect of ukrain on growth of ascites and solid forms of Ehrlich's carcinoma.
Susak YM; Skivka LM; Rudik MP; Pozur VV; Liubunya AV
Exp Oncol; 2010 Jul; 32(2):107-10. PubMed ID: 20693973
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antitumor efficacy and toxicity of novel 6-nitro-2-(3-chloropropyl)-1H-benz[de]isoquinoline-1,3-dione in vivo in mouse.
Mukherjee A; Dutta S; Sanyal U
J Cancer Res Ther; 2013; 9(3):442-6. PubMed ID: 24125980
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
Samanta S; Pain A; Dutta S; Saxena AK; Shanmugavel M; Pandita RM; Qazi GN; Sanyal U
J Exp Ther Oncol; 2005; 5(1):15-22. PubMed ID: 16416597
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity and antioxidant property of Curcuma caesia against Ehrlich's ascites carcinoma bearing mice.
Karmakar I; Dolai N; Suresh Kumar RB; Kar B; Roy SN; Haldar PK
Pharm Biol; 2013 Jun; 51(6):753-9. PubMed ID: 23527894
[TBL] [Abstract][Full Text] [Related]
9. Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation.
Wu A; Xu Y; Qian X; Wang J; Liu J
Eur J Med Chem; 2009 Nov; 44(11):4674-80. PubMed ID: 19643513
[TBL] [Abstract][Full Text] [Related]
10. 3-Nitro-naphthalimide and nitrogen mustard conjugate NNM-25 induces hepatocellular carcinoma apoptosis via PARP-1/p53 pathway.
Xie SQ; Zhang YH; Li Q; Xu FH; Miao JW; Zhao J; Wang CJ
Apoptosis; 2012 Jul; 17(7):725-34. PubMed ID: 22395446
[TBL] [Abstract][Full Text] [Related]
11. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 2-chloroethylnitrosoureas of substituted naphthalimides as mixed-function anticancer compounds.
Samanta S; Pain A; Dutta S; Sanyal U
Acta Pol Pharm; 2001; 58(5):351-6. PubMed ID: 11876442
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study.
Ferreira AK; Meneguelo R; Pereira A; Mendonça Filho O; Chierice GO; Maria DA
Anticancer Res; 2012 Jan; 32(1):95-104. PubMed ID: 22213293
[TBL] [Abstract][Full Text] [Related]
14. Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.
Wu A; Mei P; Xu Y; Qian X
Chem Biol Drug Des; 2011 Dec; 78(6):941-7. PubMed ID: 21958160
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro antitumor activity of new substituted thiopyrimidine acyclic nucleosides and their thioglycoside analogs.
El-Sayed WA; Rashad AE; Awad SM; Ali MM
Nucleosides Nucleotides Nucleic Acids; 2009 Apr; 28(4):261-74. PubMed ID: 20183580
[TBL] [Abstract][Full Text] [Related]
16. Naphthalimides and azonafides as promising anti-cancer agents.
Ingrassia L; Lefranc F; Kiss R; Mijatovic T
Curr Med Chem; 2009; 16(10):1192-213. PubMed ID: 19355879
[TBL] [Abstract][Full Text] [Related]
17. Development of novel naphthalimide derivatives and their evaluation as potential melanoma therapeutics.
Sk UH; Prakasha Gowda AS; Crampsie MA; Yun JK; Spratt TE; Amin S; Sharma AK
Eur J Med Chem; 2011 Aug; 46(8):3331-8. PubMed ID: 21609852
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antitumor activity and in vivo antioxidant status of Anthocephalus cadamba on Ehrlich ascites carcinoma treated mice.
Dolai N; Karmakar I; Suresh Kumar RB; Kar B; Bala A; Haldar PK
J Ethnopharmacol; 2012 Aug; 142(3):865-70. PubMed ID: 22705911
[TBL] [Abstract][Full Text] [Related]
19. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
[TBL] [Abstract][Full Text] [Related]
20. Unprecedented synthesis, in vitro and in vivo anti-cancer evaluation of novel triazolonaphthalimide derivatives.
Li S; Zhong W; Li Z; Meng X
Eur J Med Chem; 2012 Jan; 47(1):546-52. PubMed ID: 22138307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
